Abstract Body

Background:

Understanding the counterbalance of epitope shielding and accessibility on HIV-1 envelope (Env) trimers is essential to guide immunogen selection for broadly neutralizing antibody (bnAb) based vaccines. To investigate the antigenic space of highly stabilized Env trimers, we here created a novel strategy, DARPin Antigenicity Analysis (DANA), based on synthetic, high diversity Designed Ankyrin Repeat Protein (DARPin) libraries. We show that DANA, a purely in-vitro screening tool, has the means to inform on the antigenic properties of Env immunogens by recapitulating the difficulty of the human immune system to generate antibodies recognizing prefusion closed Env in vivo.

Methods:

High diversity DARPin libraries consist of ~19kDa-sized synthetic proteins with a consensus-designed framework and randomized residues in the binding surface. We performed 12 independent DANA screens using different SOSIP-type Env trimers as panning targets to select Env-specific DARPins from DARPin libraries by ribosome display. 190 DARPins from each DANA screen were sequenced and analyzed for trimer and V3 loop reactivity by ELISA and neutralization breadth using a 5-virus panel in the standard TZM-bl based pseudovirus neutralization assay.

Results:

Comparison of Env trimers in DANA screens revealed that stronger trimer stabilization, occluding the V3, lead to the selection of highly mutated DARPins with length variations and framework mutations. This is highly reminiscent of the extensive affinity maturation and framework mutations reported for bnAbs, indicating that DARPins and antibodies, despite their genuinely different binding architecture, have the same underlying biophysics of interaction and thus similar limitations in recognizing the shielded trimer. Notably, by exploring different selection regimens, we showed that in DANA reduction of V3 dominance benefits the selection of trimer-reactive clones, reaffirming current concepts of vaccine design. As we show, DANA screens have, next to investigating single immunogens, the capacity to mimic heterotypic prime-boost immunization regimens and to select immunogen combinations that favor the selection of trimer reactive binders.

Conclusions:

Our results demonstrate the utility of DANA screens as a versatile tool for basic antigenicity screening of immunogen candidates, which may substitute for some of the early-stage animal testing required in vaccine development.